New preprint on alpha-ketoglutarate and histone acetylation- congrats Dr. Apoorva Uboveja and co-authors

We are excited to share our newest preprint from 1st author Dr. Apoorva Uboveja. In this project, she found something totally unexpected- aKG affects histone acetylation through carnitine synthesis. This axis promoted DNA repair by homologous recombination. These data provide new evidence for a metabolically-sensitive epigenetic axis that could be targeted for cancer therapy. They also show that methylation is not the only epigenetic change that is affected by aKG. https://www.biorxiv.org/content/10.1101/2024.02.06.578742v1

New preprint alert! First authors Naveen and Raquel identify anti-folates as a strategy to treat cancers with p16 loss

Congrats to co-first authors Drs. Naveen Kumar Tangudu and Raquel Buj on their new preprint. Using CRISPR screens and pharmacological approaches, they identified purine metabolism as a metabolic vulnerability of p16-low cancers. Read more here: https://www.biorxiv.org/content/10.1101/2023.07.15.549149v2

The lab is looking to expand! Postdoc applicants and rotation students welcome!

We are looking to expand our lab team! With new anticipated funding in 2021, multiple positions are open to study metabolism, epigenetics, and senescence in cancer. We support both scientific and professional development and foster a diverse and inclusive lab environment. For more information, see: https://airdlab.com/positions.

Email Dr. Aird with a cover letter and CV if interested.